| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.0038 | 1 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.0026 | 1 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |